Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1995

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Prospects of contraception. [Perspectives de la contraception.]

AUTHORS

Christin-Maitre S; Chabbert-Buffet N; Leroy I; Bouchard P

SOURCE

REVUE DU PRATICIEN. 1995 Dec 1;45(19):2449-53.

ABSTRACT

World population will rapidly surpass 6 billion. Thus, it is necessary to increase women's access to affordable and

well-tolerated contraceptives. In the first place, women must be educated and better informed about reproductive

health and contraceptive use. Secondly, the new hormones must rapidly be made available. These new hormones

include 17beta-estradiol in the pill, low dose combined contraceptives with new non-androgenic progestins

(gestodene, desogestrel, and norgestimate), RU-486 as postcoital contraception, levonorgestrel- or desogestrel-

releasing IUDs, gonadotropin-releasing hormone agonists and antagonists, and percutaneous administration of an

anti-ovulation progestin (nestrone). In the medium-term, daily use of anti-progestins are now under research, which

suppresses endometrial maturation. In the long-term, anti-follicle stimulating hormone molecules or tissue-specific

steroids may be developed. (PubHealth.info Document ID: CONT2T 3031-06)

PubHealth.info NOTE: The author(s) of this article titled, "Prospects of contraception. [Perspectives de la

contraception.]", is(are) Christin-Maitre S; Chabbert-Buffet N; Leroy I; Bouchard P. The source of this article is

"REVUE DU PRATICIEN. 1995 Dec 1;45(19):2449-53.". This article was published in 1995 in French language(s).

(PubHealth.info® Document ID: CONT2T 3031-06. All rights reserved with PubHealth.info) PIN: 8031

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.